BLCM
Bellicum Pharmaceuticals Inc
Halal Rating :
Last Price
$0.00
Last updated:
Market Cap
-
7D Change
0.0%
1 Year Change
0.0%
Company Overview
Industries
Exchange
Next Earnings Date
Bellicum Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing novel cellular immunotherapies for cancer and other serious diseases. The company's primary focus is on developing controllable cellular immunotherapies for various forms of cancer, using their proprietary chemical induction of dimerization (CID) technology platform.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Sept. 30, 2023 | $1.0m | $1.77m | - | - | 0.00% | 0.00% |
Company Impact
Help us evaluate Bellicum Pharmaceuticals Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.